<DOC>
	<DOCNO>NCT02737826</DOCNO>
	<brief_summary>Chronic opioid therapy pain associate significant risk , significant number patient maintain chronic opioids continue pain and/or poor functioning . When patient need want come opioid pain medication , little guide physician best help , know patient come opioid medication . The goal study ( 1 ) evaluate two medication assist patient come opioid pain medication ( 2 ) determine outcomes discontinue opioids .</brief_summary>
	<brief_title>Discontinuation From Chronic Opioid Therapy For Pain Using Buprenorphine Taper</brief_title>
	<detailed_description />
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<mesh_term>Gabapentin</mesh_term>
	<mesh_term>gamma-Aminobutyric Acid</mesh_term>
	<criteria>18 55 year age Ability speak read English Currently take chronic opioid therapy pain least 6 month On opioid dose &gt; 60mg &lt; 200mg oral morphine equivalents/day Voluntarily seek opioid discontinuation Willing attempt buprenorphineassisted opioid discontinuation Willing randomize gabapentin placebo Have current physician actively prescribe opioids notify research team patient 's entry study . Previous intolerance allergy buprenorphine gabapentin Diagnostic &amp; Statistical Manual V criterion substance use disorder currently past ( nicotine ) Unstable medical psychiatric condition would preclude safe meaningful participation ( e.g . traumatic brain injury ; severe mental illness ; severe cardiac , renal , pulmonary , liver disease ) Current use benzodiazepine illicit drug Maintenance fentanyl methadone Current treatment gabapentin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>